Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PCOS is a common hormonal disorder in women linked to several health risks and can be managed through various treatments.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

PCOS causes hormonal imbalance, irregular periods, and can lead to obesity.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Acne and PCOS are linked due to hormonal imbalances and metabolic issues.

Gastric bypass surgery improved a woman's hormonal disorder without the need for medication.

Androgenetic alopecia is a common genetic and hormonal hair loss affecting many men and women.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

PCOS, aging, and fertility are linked by hormonal and metabolic issues, with lifestyle changes and treatments offering potential help.

In teens with Polycystic Ovary Syndrome and obesity, issues related to metabolism, skin, and mental health are common, and a clinic with various specialists can provide care for most of these problems.

Male hair loss is mainly due to androgens, while female hair loss involves hormones, vitamins, and genetics.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Males and females differ in lifespan, growth, organ size, metabolism, and brain structure, with females generally living longer and maturing earlier.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

Hormonal balance is vital for women's health and performance, but therapies like contraceptives and steroids have both benefits and risks.

Finasteride 1 mg reduces semen quality without affecting hormones.

Finasteride 1 mg/day reduces semen quality without affecting hormones or sexual function.

Metformin is less effective in men with early-onset hair loss.

Palash basti improved PMOS symptoms in a 26-year-old woman.

Androgenetic alopecia is linked to insulin resistance and hormonal imbalances.

Taking 1 mg finasteride for a year reduces dihydrotestosterone levels in men with early hair loss, but doesn't change their metabolic state.

Hormonal treatments can effectively improve hidradenitis suppurativa symptoms.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Most women with excessive hair growth in South India have hirsutism without a known cause, with common facial hair growth and some showing hormonal imbalances and polycystic ovaries.

Androgenetic alopecia is linked to aging due to inflammation, oxidative stress, and hormonal changes.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.